Heart News and Research

RSS

Five important things to know about the new opt out organ donation law

From 20 May 2020, all adults in England are automatically considered potential organ donors following the introduction of the Organ Donation (Deemed Consent) Bill.

26 May 2020

RCSI and LEO Pharma team up to investigate the role of blood clotting protein in breast cancer

RCSI University of Medicine and Health Sciences and LEO Pharma have partnered to better understand the role of a blood clotting protein in the spread of breast cancer.

26 May 2020

Higher spirituality linked to better quality of life for stroke survivors and their caregivers

Higher spirituality among stroke survivors was strongly linked to better quality of life for them and their caregivers who may also feel depressed, according to new research published today in Circulation: Cardiovascular Quality and Outcomes, an American Heart Association journal.

26 May 2020

Genes associated with dementia doubles the risk of developing severe COVID-19

Having a faulty gene linked to dementia doubles the risk of developing severe COVID-19, according to a large-scale study.

26 May 2020

Challenges of diagnosing Lyme disease in the absence of classic symptoms

Lyme disease can have unusual presentations. Physicians and the public should be aware of its different manifestations, as people spend more time outside in the warmer weather and as the areas in Canada where the black legged tick is found expand.

26 May 2020

Researchers find a 'skinny' gene

Some people may have trouble losing weight, while others find it hard to gain weight. Now, a team of scientists may have found the answer to why some people remain thin despite eating without restriction.

26 May 2020

Heart failure patients who experience low health literacy have higher risk of death of hospitalization, mortality

Patients with heart failure who experience low health literacy are at an increased risk of hospitalization and mortality.

26 May 2020

Zero benefit of Hydroxychloroquine or Chloroquine in COVID-19, says extensive study

The purported "game-changer" anti-malarial drug Hydroxychloroquine, which was claimed to be effective in preventing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and also helping better outcomes in COVID-19 patients, seems to have failed in clinical trials.

25 May 2020

Capillary leakage important in COVID-19 respiratory distress

Now, a new study published on the preprint server medRxiv reports the pivotal role played by protein leakage through lung capillaries and promotes the use of serum albumin as a biomarker of disease progression and severity.

24 May 2020

Teens develop septic shock due to COVID-19

Since the emergence of the novel coronavirus disease (COVID-19), most people who develop severe illness are older adults, those with underlying medical conditions, and those who are immunocompromised. Though children are mostly spared, some adolescents developed septic shock due to COVID-19, a new study has found.

24 May 2020

Blood test could help doctors identify patients at risk of developing type 2 diabetes

Scientists have identified metabolites in the blood that accurately predict whether a woman will develop type 2 diabetes after experiencing a transient form of illness during pregnancy.

22 May 2020

Treatment with chloroquine or hydroxychloroquine offers no benefit for COVID-19 patients

A large observational study suggests that treatment with the antimalarial drug chloroquine or its analog hydroxychloroquine (taken with or without the antibiotics azithromycin or clarithromycin) offers no benefit for patients with COVID-19.

22 May 2020

Women and older adults still vastly underrepresented in cholesterol drug trials

Although heart disease is the leading cause of death in women, and older adults are more likely to have heart and vascular disease than young people, randomized clinical trials testing medications to lower cholesterol have historically underenrolled both groups.

22 May 2020

Blanket prescription of do-not-resuscitate orders in COVID-19 patients may be unwarranted

It's inappropriate to consider blanket do-not-resuscitate orders for COVID-19 patients because adequate data is not yet available on U.S. survival rates for in-hospital resuscitation of COVID-19 patients and data from China may not relate to U.S. patients, according to a new article published today in Circulation: Cardiovascular Quality and Outcomes, an American Heart Association journal.

22 May 2020

Study identifies risk factors for severe COVID-19 or death in the UK

Age, male sex, obesity, and underlying illness have emerged as risk factors for severe covid-19 or death in the UK, according to the largest cohort study to date published by The BMJ today.

22 May 2020

Children's National receives FCC funding to establish regional pediatric telehealth consortium

Children's National Hospital is establishing a regional pediatric telehealth consortium in response to coronavirus with $928,000 in funding awarded by the Federal Communications Commission's Wireline Competition Bureau.

22 May 2020

Coronavirus tests the value of artificial intelligence in medicine

Dr. Albert Hsiao and his colleagues at the University of California-San Diego health system had been working for 18 months on an artificial intelligence program designed to help doctors identify pneumonia on a chest X-ray. When the coronavirus hit the United States, they decided to see what it could do.

22 May 2020

Heart News and Research

Five important things to know about the new opt out organ donation law

RCSI and LEO Pharma team up to investigate the role of blood clotting protein in breast cancer

Higher spirituality linked to better quality of life for stroke survivors and their caregivers

Genes associated with dementia doubles the risk of developing severe COVID-19

Challenges of diagnosing Lyme disease in the absence of classic symptoms

Researchers find a 'skinny' gene

Heart failure patients who experience low health literacy have higher risk of death of hospitalization, mortality

Zero benefit of Hydroxychloroquine or Chloroquine in COVID-19, says extensive study

Capillary leakage important in COVID-19 respiratory distress

Teens develop septic shock due to COVID-19

Blood test could help doctors identify patients at risk of developing type 2 diabetes

Treatment with chloroquine or hydroxychloroquine offers no benefit for COVID-19 patients

Women and older adults still vastly underrepresented in cholesterol drug trials

Blanket prescription of do-not-resuscitate orders in COVID-19 patients may be unwarranted

Study identifies risk factors for severe COVID-19 or death in the UK

Children's National receives FCC funding to establish regional pediatric telehealth consortium

Coronavirus tests the value of artificial intelligence in medicine

Point-of-care, wearable devices are set to diagnose common health conditions

Improving IVF Treatments by Imaging Sperm Cells

Despite low stroke rates among COVID-19 patients, cases are still more severe

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News